{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:00:20Z","timestamp":1789783220723,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2004,7,14]],"date-time":"2004-07-14T00:00:00Z","timestamp":1089763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s00213-004-1919-2","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T12:22:26Z","timestamp":1089721346000},"page":"15-22","source":"Crossref","is-referenced-by-count":38,"title":["Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression"],"prefix":"10.1007","volume":"177","author":[{"given":"Andrew F.","family":"Leuchter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dunkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,14]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archpsyc.57.3.285","volume":"57","author":"Alexopoulos","year":"2000","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J (2000) Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 57:285?290","journal-title":"Arch Gen Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(99)00679-5","volume":"274","author":"Asada","year":"1999","unstructured":"Asada H, Fukuda Y, Tsunoda S, Yamaguchi M, Tonoike M (1999) Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 274:29?32","journal-title":"Neurosci Lett"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1955.02960340022006","volume":"159","author":"Beecher","year":"1955","unstructured":"Beecher HK (1955) The powerful placebo. JAMA 159:1602?1606","journal-title":"JAMA"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0028-3932(68)90038-9","volume":"6","author":"Benton","year":"1968","unstructured":"Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53?60","journal-title":"Neuropsychologia"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneur.1978.00500300038006","volume":"35","author":"Benton","year":"1978","unstructured":"Benton AL, Varney NR, Hamsher KD (1978) Visuospatial judgment. A clinical test. Arch Neurol 35:364?367","journal-title":"Arch Neurol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0013-4694(94)00234-C","volume":"94","author":"Brenner","year":"1995","unstructured":"Brenner RP, Ulrich RF, Reynolds CF (1995) EEG spectral findings in healthy elderly men and women?sex differences. EEG Clin Neurophys 94:1?5","journal-title":"EEG Clin Neurophys"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0013-4694(98)00092-3","volume":"107","author":"Cook","year":"1998","unstructured":"Cook IA, O?Hara R, Uijtdehaage S, Mandelkern M, Leuchter AF (1998) Assessing the accuracy of topographic EEG mapping for determining local brain function. EEG Clin Neurophys 107:404?414","journal-title":"EEG Clin Neurophys"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0165-1781(99)00010-4","volume":"85","author":"Cook","year":"1999","unstructured":"Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SHJ, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C (1999) Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res 85:263?273","journal-title":"Psychiatry Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0327(99)00157-3","volume":"60","author":"Dunkin","year":"2000","unstructured":"Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S (2000) Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 60:13?23","journal-title":"J Affect Disord"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.284.5412.238","volume":"284","author":"Enserlink","year":"1999","unstructured":"Enserlink M (1999) Psychopharmacology: can the placebo be the cure? Science 284:238?240","journal-title":"Science"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004714-200112000-00004","volume":"21","author":"Faries","year":"2001","unstructured":"Faries DE, Heiligenstein JH, Tollefson GD, Potter WZ (2001) The double-blind variable placebo lead-in period: results from two antidepressant clinical trials. J Clin Psychopharm 21:561?568","journal-title":"J Clin Psychopharm"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","volume":"72","author":"Fava","year":"2003","unstructured":"Fava M, Evins AE, Dorer DJ, Schoenfeld DA (2003) The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom 72:115?127","journal-title":"Psychother Psychosom"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56?62","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00001756-199903170-00003","volume":"10","author":"Ishii","year":"1999","unstructured":"Ishii R, Shinosaki K, Ukai S, Inouye T, Ishihara T, Yoshimine T, Hirabuke N, Asada H, Kihara T, Robinson SE, Takeda M (1999) Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 10:675?679","journal-title":"Neuroreport"},{"key":"CR15","unstructured":"Kaplan E, Goodglass H, Weintraub S (1983) Boston Naming Test. Lea & Febiger, Philadelphia, PA"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.0006-341X.2000.00271.x","volume":"56","author":"Landin","year":"2000","unstructured":"Landin R, DeBrota DJ, DeVries TA, Potter WZ, Demitrack MA (2000) The impact of restrictive entry criterion during the placebo lead-in period. Biometrics 56:271?278","journal-title":"Biometrics"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/brain\/115.5.1543","volume":"115","author":"Leuchter","year":"1992","unstructured":"Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA (1992) Changes in brain functional connectivity in Alzheimer?s-type and multi-infarct dementia. Brain 115:1543?1561","journal-title":"Brain"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/nimg.1994.1006","volume":"1","author":"Leuchter","year":"1994","unstructured":"Leuchter AF, Cook IA, Lufkin RB, Dunkin J, Newton TF, Cummings JL, Mackey K, Walter D (1994a) Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1:208?219","journal-title":"Neuroimage"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0925-4927(94)90022-1","volume":"55","author":"Leuchter","year":"1994","unstructured":"Leuchter AF, Cook IA, Mena I, Dunkin J, Cummings JL, Newton T, Migneco O, Lufkin R, Walter D, Lachenbruch P (1994b) Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res Neuroimaging 55:141?152","journal-title":"Psychiatry Res Neuroimaging"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0925-4927(99)00006-2","volume":"90","author":"Leuchter","year":"1999","unstructured":"Leuchter AF, Uijtdehaage SH, Cook IA, O?Hara R, Mandelkern M (1999) Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res Neuroimaging 90:125?140","journal-title":"Psychiatry Res Neuroimaging"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/appi.ajp.159.1.122","volume":"159","author":"Leuchter","year":"2002","unstructured":"Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159:122?129","journal-title":"Am J Psychiatry"},{"key":"CR22","unstructured":"Lezak MD (1983) Neuropsychological Assessment. Oxford University, New York"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00001756-199703030-00048","volume":"8","author":"Mayberg","year":"1997","unstructured":"Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS et al (1997) Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8:1057?1061","journal-title":"Neuroreport"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4088\/JCP.v61n0710","volume":"61","author":"McGrath","year":"2000","unstructured":"McGrath PJ, Stewart JW, Petkova E, Quitkin FM, Amsterdam JD, Fawcett J, Reimherr FW, Rosenbaum JF, Beasley CM Jr (2000) Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. J Clin Psychiatry 61:518?524","journal-title":"J Clin Psychiatry"},{"key":"CR25","unstructured":"Michelson D, Holland P, Tepner R, Pemberton C (1999) Double-blind vs. single-blind placebo lead-in periods during panic disorder efficacy trials. Poster presented at the 39th Annual NCDEU Meeting. Boca Raton, FL"},{"key":"CR26","first-page":"1848","volume":"159","author":"Peselow","year":"1992","unstructured":"Peselow ED, Sanfilipo MP, Difiglia C, Fieve RR (1992) Melancholic\/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 159:1848?1854","journal-title":"Am J Psychiatry"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1176\/ajp.156.6.829","volume":"156","author":"Quitkin","year":"1999","unstructured":"Quitkin FM (1999) Placebos, drug effects and study design: a clinician?s guide. Am J Psychiatry 156:829?836","journal-title":"Am J Psychiatry"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000292465","volume":"163","author":"Quitkin","year":"1993","unstructured":"Quitkin FM, Stewart JW, McGrath PJ (1993) Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry 163:30?34","journal-title":"Br J Psychiatry"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(89)90160-1","volume":"30","author":"Reimherr","year":"1989","unstructured":"Reimherr FW, Ward MF, Byerley WF (1989) The introductory placebo washout: a retrospective evaluation. Psychiatry Res 30:191?199","journal-title":"Psychiatry Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"Reitan","year":"1958","unstructured":"Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271?276","journal-title":"Percept Mot Skills"},{"key":"CR31","first-page":"286","volume":"28","author":"Rey","year":"1941","unstructured":"Rey A (1941) L?examen psychologique dans les cas d?encephalopathie traumatique. Arch Psychol 28:286?340","journal-title":"Arch Psychol"},{"key":"CR32","unstructured":"Rey A (1964) L?examen clinique en psychologie. Pressess Universitiaires de France, Paris"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00004714-200012000-00001","volume":"20","author":"Robinson","year":"2000","unstructured":"Robinson DS, Rickels K (2000) Concern about clinical drug trials. J Clin Psychopharmacol 20:593?596","journal-title":"J Clin Psychopharmacol"},{"key":"CR34","first-page":"from","volume":"Placebo","author":"Shapiro","year":"1997","unstructured":"Shapiro AK, Shapiro E (1997) The Powerful Placebo: from Ancient Priest to Modern Physician. Johns Hopkins University, Baltimore","journal-title":"The Powerful"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archpsyc.55.4.334","volume":"55","author":"Stewart","year":"1998","unstructured":"Stewart JW, Quitkin FM, McGrath PJ, Amsterdam J, Fava MD, Fawcett J, Reimherr F, Rosenbaum J, Beasley C, Roback P (1998) Use of pattern analysis to predict differential relapse of remitted patients with major depression during one year of treatment with fluoxetine or placebo. Arch Gen Psychiatry 55:334?343","journal-title":"Arch Gen Psychiatry"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"12","author":"Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 12:643?662","journal-title":"J Exp Psychol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1227\/00006123-198507000-00007","volume":"17","author":"Stuss","year":"1985","unstructured":"Stuss DT, Ely P, Hugenholtz H, Richard MT, LaRochelle S, Poirier CA, Bell I (1985) Subtle neuropsychological deficits in patients with good recovery after closed head injury. Neurosurgery 17:41?47","journal-title":"Neurosurgery"},{"key":"CR38","first-page":"293","volume":"29","author":"Thase","year":"1993","unstructured":"Thase ME, Simons AD, Reynolds CF (1993) Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacol Bull 29:293?301","journal-title":"Psychopharmacol Bull"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/npp.1994.63","volume":"11","author":"Trivedi","year":"1994","unstructured":"Trivedi MH, Rush H (1994) Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 11:33?43","journal-title":"Neuropsychopharmacology"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-2007-1017433","volume":"17","author":"Ulrich","year":"1984","unstructured":"Ulrich G, Renfordt E, Zeller G, Frick K (1984) Interrelation between change in the EEG and psychopathology under pharmacotherapy for endogenous depression: a contribution to the predictor question. Pharmacopsychiatry 17:178?183","journal-title":"Pharmacopsychiatry"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0327(94)90020-5","volume":"32","author":"Ulrich","year":"1994","unstructured":"Ulrich G, Haug HJ, Fahndrich E (1994) Acute versus chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome. J Affect Disord 32:213?217","journal-title":"J Affect Disord"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","volume":"287","author":"Walsh","year":"2002","unstructured":"Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial and growing. JAMA 287:1840?1847","journal-title":"JAMA"},{"key":"CR43","unstructured":"Wechsler D (1981) Manual for the Wechsler Adult Intelligence Scale?revised. Psychological Corporation, New York"},{"key":"CR44","unstructured":"Wechsler D (1987) Manual for the Wechsler Memory Scale?revised. Psychological Corporation, New York"},{"key":"CR45","unstructured":"Woodcock RW, Johnson MB (1977) Woodcock-Johnson Psycho-Educational Battery. DLM Teaching Resources, Allen, Texas"},{"key":"CR46","doi-asserted-by":"crossref","unstructured":"Zimbroff DL, Mendez, G (2002) Patient and rater education about expectations in clinical trials (PREECT): an approach to reducing placebo response rates and improving signal detection in psychopharmacology trials. Poster presented at the 42nd Annual NCDEU Meeting. Boca Raton, FL","DOI":"10.1016\/S0924-977X(01)80146-2"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1919-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-1919-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1919-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T18:28:56Z","timestamp":1585852136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-1919-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,14]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-1919-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,14]]}}}